Caeser, Rebecca
Di Re, Miriam
Krupka, Joanna A. http://orcid.org/0000-0003-0369-0329
Gao, Jie
Lara-Chica, Maribel http://orcid.org/0000-0003-2908-9929
Dias, João M. L. http://orcid.org/0000-0002-8451-3537
Cooke, Susanna L.
Fenner, Rachel
Usheva, Zelvera
Runge, Hendrik F. P. http://orcid.org/0000-0002-4282-1515
Beer, Philip A.
Eldaly, Hesham
Pak, Hyo-Kyung
Park, Chan-Sik
Vassiliou, George S. http://orcid.org/0000-0003-4337-8022
Huntly, Brian J. P. http://orcid.org/0000-0003-0312-161X
Mupo, Annalisa
Bashford-Rogers, Rachael J. M. http://orcid.org/0000-0002-6838-0711
Hodson, Daniel J. http://orcid.org/0000-0001-6225-2033
Article History
Received: 15 April 2019
Accepted: 11 September 2019
First Online: 4 October 2019
Competing interests
: D.J.H.: Research funding from Gilead Sciences; Consultancy for Karus Therapeutics. P.A.B.: consultancy for Karus Therapeutics (Oxford, UK), OncoDNA (Gosselies, Belgium), and Everything Genetic (London, UK). The remaining authors declare no competing interests.